![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
EJ Cone, CW Gorodetzky, D Yousefnejad, WF Buchwald and RE Johnson
Buprenorphine, a powerful mixed agonist-antagonist analgesic which shows promise of providing maintenance pharmacotherapy for heroin addicts, is metabolized in male human subjects to norbuprenorphine and to conjugated buprenorphine and norbuprenorphine. Following subcutaneous, sublingual, and oral buprenorphine administration to a single subject, total metabolite excretion in urine was 2, 13.4, and 12.1%, respectively. No free parent drug was detected in urine. The amount of norbuprenorphine metabolite excreted in urine generally exceeded that of conjugated buprenorphine. In contrast, free and conjugated buprenorphine equaled or greatly exceeded total norbuprenorphine content in fecal samples following oral or sublingual administration. The greatest amount of drug and metabolite eliminated in feces occurred at 4 to 6 days following buprenorphine administration at times when there was very little urinary excretion of conjugated buprenorphine. This latter evidence indicates an enterohepatic circulation of buprenorphine in humans.
This article has been cited by other articles:
|
|
 |
|
  R. S. Goodwin, D. G. Wilkins, O. Averin, R. E. Choo, J. R. Schroeder, D. R. Jasinski, R. E. Johnson, H. E. Jones, and M. A. Huestis Buprenorphine and Norbuprenorphine in Hair of Pregnant Women and Their Infants after Controlled Buprenorphine Administration Clin. Chem., December 1, 2007; 53(12): 2136 - 2143. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Yassen, J. Kan, E. Olofsen, E. Suidgeest, A. Dahan, and M. Danhof Pharmacokinetic-Pharmacodynamic Modeling of the Respiratory Depressant Effect of Norbuprenorphine in Rats J. Pharmacol. Exp. Ther., May 1, 2007; 321(2): 598 - 607. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Chang, D. E. Moody, and E. F. McCance-Katz NOVEL METABOLITES OF BUPRENORPHINE DETECTED IN HUMAN LIVER MICROSOMES AND HUMAN URINE Drug Metab. Dispos., March 1, 2006; 34(3): 440 - 448. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Ciraulo, R. J. Hitzemann, E. Somoza, C. M. Knapp, J. Rotrosen, O. Sarid-Segal, A. M. Ciraulo, D. J. Greenblatt, and C. N. Chiang Pharmacokinetics and Pharmacodynamics of Multiple Sublingual Buprenorphine Tablets in Dose-Escalation Trials J. Clin. Pharmacol., February 1, 2006; 46(2): 179 - 192. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Picard, T. Cresteil, N. Djebli, and P. Marquet IN VITRO METABOLISM STUDY OF BUPRENORPHINE: EVIDENCE FOR NEW METABOLIC PATHWAYS Drug Metab. Dispos., May 1, 2005; 33(5): 689 - 695. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. V. Deshmukh, T. N. Nanovskaya, and M. S. Ahmed Aromatase Is the Major Enzyme Metabolizing Buprenorphine in Human Placenta J. Pharmacol. Exp. Ther., September 1, 2003; 306(3): 1099 - 1105. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Nanovskaya, S. Deshmukh, M. Brooks, and M. S. Ahmed Transplacental Transfer and Metabolism of Buprenorphine J. Pharmacol. Exp. Ther., January 1, 2002; 300(1): 26 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kilicarslan and E. M. Sellers Lack of Interaction of Buprenorphine With Flunitrazepam Metabolism Am J Psychiatry, July 1, 2000; 157(7): 1164 - 1166. [Abstract] [Full Text]
|
|
|
|
|
|
K. Kobayashi, T. Yamamoto, K. Chiba, M. Tani, N. Shimada, T. Ishizaki, and Y. Kuroiwa Human Buprenorphine N-Dealkylation Is Catalyzed by Cytochrome P450 3A4 Drug Metab. Dispos., August 1, 1998; 26(8): 818 - 821. [Abstract] [Full Text]
|
|
|
|
|
|
E. T. Everhart, P. Cheung, P. Shwonek, K. Zabel, E. C. Tisdale, P. Jacob III, J. Mendelson, and R. T. Jones Subnanogram-concentration measurement of buprenorphine in human plasma by electron-capture capillary gas chromatography: application to pharmacokinetics of sublingual buprenorphine Clin. Chem., December 1, 1997; 43(12): 2292 - 2302. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
